These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
161 related articles for article (PubMed ID: 7394328)
1. Diester metabolites of the flame retardant chemicals, tris(1,3-dichloro-2-propyl)phosphate and tris(2,3-dibromopropyl) phosphate in the rat: identification and quantification. Lynn RK; Wong K; Dickinson RG; Gerber N; Kennish JM Res Commun Chem Pathol Pharmacol; 1980 May; 28(2):351-60. PubMed ID: 7394328 [No Abstract] [Full Text] [Related]
2. Disposition of the flame retardant, tris(1,3-dichloro-2-propyl) phosphate, in the rat. Lynn RK; Wong K; Garvie-Gould C; Kennish JM Drug Metab Dispos; 1981; 9(5):434-41. PubMed ID: 6117442 [TBL] [Abstract][Full Text] [Related]
3. Irreversible macromolecular binding of the flame retardant tris-(2, 3-dibromopropyl)phosphate in vitro and in vivo. Dybing E; Söderlund EJ; Nelson SD Dev Toxicol Environ Sci; 1980; 8():265-8. PubMed ID: 7308025 [No Abstract] [Full Text] [Related]
5. A comparison of the genotoxic properties of tris(2,3-dibromopropyl)phosphate and tris(1,3-dichloro-2-propyl)phosphate in a battery of short-term bioassays. Brusick D; Matheson D; Jagannath DR; Goode S; Lebowitz H; Reed M; Roy G; Benson S J Environ Pathol Toxicol; 1979 Dec; 3(1-2):207-26. PubMed ID: 121137 [No Abstract] [Full Text] [Related]
6. Another flame retardant, tris-(1,3-dichloro-2-propyl)-phosphate, and its expected metabolites are mutagens. Gold MD; Blum A; Ames BN Science; 1978 May; 200(4343):785-7. PubMed ID: 347576 [TBL] [Abstract][Full Text] [Related]
7. Pathogenesis of toxic and neoplastic renal lesions induced by the flame retardant tris (2,3-dibromopropyl)phosphate in F344 rats, and development of colonic adenomas after prolonged oral administration. Reznik G; Reznik-Schüller HM; Rice JM; Hague BF Lab Invest; 1981 Jan; 44(1):74-83. PubMed ID: 7453132 [TBL] [Abstract][Full Text] [Related]
8. The metabolism and disposition of tris(1,3-dichloro-2-propyl) phosphate (Fyrol FR-2) in the rat. Nomeir AA; Kato S; Matthews HB Toxicol Appl Pharmacol; 1981 Mar; 57(3):401-13. PubMed ID: 7222047 [No Abstract] [Full Text] [Related]
9. Thermal oxidative degradation studies of phosphate esters. Paciorek KJ; Kratzer RH; Kaufman J; Nakahara JH; Christos T; Hartstein AM Am Ind Hyg Assoc J; 1978 Aug; 39(8):633. PubMed ID: 696625 [TBL] [Abstract][Full Text] [Related]
10. Metabolism, distribution, and excretion of the flame retardant, tris(2,3-dibromopropyl) phosphate (tris-bp) in the rat: identification of mutagenic and nephrotoxic metabolites. Lynn RK; Garvie-Gould C; Wong K; Kennish JM Toxicol Appl Pharmacol; 1982 Mar; 63(1):105-19. PubMed ID: 7071866 [No Abstract] [Full Text] [Related]
11. Quantification of two urinary metabolites of organophosphorus flame retardants by solid-phase extraction and gas chromatography-tandem mass spectrometry. Schindler BK; Förster K; Angerer J Anal Bioanal Chem; 2009 Oct; 395(4):1167-71. PubMed ID: 19763550 [TBL] [Abstract][Full Text] [Related]
12. Metabolism of tris(2-chloroethyl) phosphate in rats and mice. Burka LT; Sanders JM; Herr DW; Matthews HB Drug Metab Dispos; 1991; 19(2):443-7. PubMed ID: 1676651 [TBL] [Abstract][Full Text] [Related]
13. Determination of human urinary organophosphate flame retardant metabolites by solid-phase extraction and gas chromatography-tandem mass spectrometry. Schindler BK; Förster K; Angerer J J Chromatogr B Analyt Technol Biomed Life Sci; 2009 Feb; 877(4):375-81. PubMed ID: 19121980 [TBL] [Abstract][Full Text] [Related]
14. First insights in the metabolism of phosphate flame retardants and plasticizers using human liver fractions. Van den Eede N; Maho W; Erratico C; Neels H; Covaci A Toxicol Lett; 2013 Oct; 223(1):9-15. PubMed ID: 23994729 [TBL] [Abstract][Full Text] [Related]
15. Mutagenicity of Tris(2,3-dibromopropyl) phosphate in mammalian gonad and bone marrow tissue. Salamone MF; Katz M J Natl Cancer Inst; 1981 Apr; 66(4):691-5. PubMed ID: 6939915 [TBL] [Abstract][Full Text] [Related]
16. Metabolic activation of tris(2,3-dibromopropyl)phosphate to reactive intermediates. I. Covalent binding and reactive metabolite formation in vitro. Pearson PG; Omichinski JG; McClanahan RH; Søderlund EJ; Dybing E; Nelson SD Toxicol Appl Pharmacol; 1993 Feb; 118(2):186-95. PubMed ID: 8441997 [TBL] [Abstract][Full Text] [Related]
17. [The structures of two chemicals sometimes misunderstood as tris-(2,3-dibromopropyl)phosphate in the official analytical method]. Nakamura A; Kojima S; Kaniwa M Eisei Shikenjo Hokoku; 1986; (104):109-13. PubMed ID: 3567421 [No Abstract] [Full Text] [Related]
18. Metabolic activation of tris(2,3-dibromopropyl)phosphate to reactive intermediates. II. Covalent binding, reactive metabolite formation, and differential metabolite-specific DNA damage in vivo. Pearson PG; Omichinski JG; Holme JA; McClanahan RH; Brunborg G; Søderlund EJ; Dybing E; Nelson SD Toxicol Appl Pharmacol; 1993 Feb; 118(2):196-204. PubMed ID: 8441998 [TBL] [Abstract][Full Text] [Related]
19. Seasonal fluctuations of organophosphate concentrations in precipitation and storm water runoff. Regnery J; Püttmann W Chemosphere; 2010 Feb; 78(8):958-64. PubMed ID: 20074776 [TBL] [Abstract][Full Text] [Related]
20. In vivo binding of the flame retardants tris(2,3-dibromopropyl) phosphate and tris(1,3-dichloro-2-propyl) phosphate to macromolecules of mouse liver, kidney and muscle. Morales NM; Matthews HB Bull Environ Contam Toxicol; 1980 Jul; 25(1):34-8. PubMed ID: 6161654 [No Abstract] [Full Text] [Related] [Next] [New Search]